Apigenin has been shown to be effective in cell culture, inhibiting IKKα/β phosphorylation and downstream NF-ĸB signaling in human prostate cancer PC-3 and 22Rv1 cells; therefore, we extended our study to determine whether these events occur in vivo using xenograft mouse model. This evidence concerns the gene CHUK and prostate carcinoma.